Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Debt Issued

Intercept Pharmaceuticals Debt Issued Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Debt Issued from 2016 to 2019.
  • Intercept Pharmaceuticals Debt Issued for the quarter ending December 12, 2019 was $0m a 0.00% increase of 261m year over year
  • Intercept Pharmaceuticals Debt Issued for the last 12 months ending June 06, 2020 was $0m a 0.00% decrease of -223m year over year
  • Intercept Pharmaceuticals Annual Debt Issued for 2019 was $223m a -100.32% decrease of -224m from 2018
  • Intercept Pharmaceuticals Annual Debt Issued for 2016 was $448m
Other Cash Flow Metrics:
  • Intercept Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-52m a -48.23% increase of 25m year over year
  • Intercept Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-25m a -40.86% increase of 10m year over year
  • Intercept Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $47m a 19.79% increase of 9m year over year
View Chart On Koyfin

Quarterly ICPT Debt Issued Data

12/2019$0m
09/2019$0m
06/2019$223m
09/2018$-261m
06/2018$261m
12/2016$0m
09/2016$448m

Annual ICPT Debt Issued Data

2019$223m
2016$448m